Stories tagged with "eli lilly and co"

Bill reduces proposed fees on medical device makers by indystar

WASHINGTON — The Senate scaled back proposed fees on Eli Lilly and Co., Cook Medical and other makers of medical devices as part of the health-care bill that could get its... – Nov 21, 2009 at 12:00 AM in Politics & Government

Retiring Lilly research exec Steven Paul gets $2 million in severance by John Russell

The top research executive at Eli Lilly and Co. will receive a $2 million cash severance payment and be credited with extra years of service when he retires in February — a... – Nov 20, 2009 at 12:00 AM in Business

Top Eli Lilly researcher Paul's payout: $2M by John Russell

As struggling Indianapolis drugmaker Eli Lilly and Co. slashes thousands of jobs and trims benefits for employees, one top executive is getting a handsome retirement payout. The... – Nov 19, 2009 at 11:00 AM in Business

Rival: Sex drug acts faster than Viagra, Eli Lilly's Cialis by indystar

A drug being developed by a California company was shown in a trial to be effective in 30 minutes or less, much faster than its competitors, the maker of treatments for erectile... – Nov 18, 2009 at 12:42 PM in Business

With $12M gift, Eli Lilly stays No. 1 United Way donor by Tom Spalding

Eli Lilly and Co. is poised to retain its title as the No. 1 donor to United Way of Central Indiana as executives with the Indianapolis drugmaker today pledged $12 million to the... – Nov 16, 2009 at 11:14 AM in Business

Lilly's big cancer bet: seeking new blockbusters by John Russell

While the risks are huge, the rewards could be giant In a corner of an Eli Lilly and Co. cancer laboratory, biologist Julie Pomeroy squeezes drops of a fluorescent stain onto mice... – Nov 15, 2009 at 1:08 AM in Health Care & Pharma

Lilly's research chief to retire in February by John Russell

Steven Paul to leave in February; successor now at AstraZeneca Dr. Steven M. Paul, the top research executive at Eli Lilly and Co. who helped launch antidepressant Cymbalta and... – Nov 14, 2009 at 12:00 AM in Health Care & Pharma

Top Eli Lilly researcher Steven Paul to retire by John Russell

The top research executive at Eli Lilly and Co. will retire in February, the Indianapolis drugmaker announced today, and will be succeeded by the top researcher at European... – Nov 13, 2009 at 11:10 AM in Business

Lilly to pay $24M settlement to Utah over Zyprexa claims by indystar

Salt Lake City — Eli Lilly and Co. has agreed to a $24 million civil settlement with the state of Utah over claims the drug maker engaged in off-label marketing of the... – Nov 12, 2009 at 12:00 AM in Health Care & Pharma

House will add new home by agammill

Christel House charter on Southside will expand to include high school Christel DeHaan’s educational philanthropy has taken her around the globe, building schools for the... – Nov 10, 2009 at 12:45 AM in South Marion County

Drug makers find whistle-blowing a bitter pill to swallow by John Russell

Employees who expose wrongdoing are forcing billions in payouts If rising costs and demanding regulators aren’t enough to torment pharmaceutical executives, here’s one... – Nov 04, 2009 at 12:49 AM in Health Care & Pharma

Biologic drugs could face competition from generics by indystar

Health-care reform bills call for 12 years of exclusivity WASHINGTON — A fast-growing category of prescription drugs that are among the most expensive on the market could,... – Nov 04, 2009 at 12:00 AM in Health Care & Pharma

Lilly, Amylin get OK for use of diabetes drug by itself by indystar

Indianapolis — Federal authorities have approved a synthetic hormone co-marketed by Eli Lilly and Co. and another pharmaceutical business for use without other medications.... – Nov 03, 2009 at 12:00 AM in Health Care & Pharma

Lilly to cut up to 191 workers in Indiana by end of 2009 by indystar

Eli Lilly and Co. has informed the Indiana Department of Workforce Development that it will cut up to 191 employees in a restructuring of its osteoporosis, diabetes and... – Nov 03, 2009 at 12:00 AM in Health Care & Pharma

Byetta gains approval as stand-alone diabetes drug by indystar

Federal authorities have approved a synthetic hormone co-marketed by Eli Lilly and Co. and another pharmaceutical business for use without other medications, according to a... – Nov 02, 2009 at 7:42 AM in Business

Indiana Democrats guarded about bill by indystar

Carson voices support for new House version, but the state’s Republicans remain opposed WASHINGTON — Indiana Democrats were noncommittal about the latest version of the... – Oct 30, 2009 at 12:45 AM in Politics & Government

Lilly opens biotech center in San Diego by John Russell

Nearly 200 scientists to key on cancer, diabetes, autoimmune ills Eli Lilly and Co. is taking another big step in its goal to become a major biotechnology player, opening a... – Oct 30, 2009 at 12:00 AM in Health Care & Pharma

Lilly opening California biotech center by indystar

Eli Lilly and Co. is taking another big step in its goal to become a major biotechnology player, announcing today that it has opened a new, sprawling complex in San Diego that will... – Oct 29, 2009 at 5:32 PM in Business

Zyprexa suit settled for $45M by indystar

Columbia, S.C. — South Carolina’s attorney general said Friday the state has reached a $45 million settlement with drug maker Eli Lilly and Co. over its marketing of an... – Oct 24, 2009 at 12:00 AM in Business

GE to work more closely with Lilly on cancer research by indystar

Indianapolis — General Electric Co., as part of its $6 billion Healthymagination project, plans to work more closely with Eli Lilly and Co. on cancer research, and said it... – Oct 23, 2009 at 12:00 AM in Business